Cross-institution positioning
Sep 4, 2026Strong institutional accumulation. 3 accumulating across 3 comparable institutions.
Source: Schedule 13 researchLazard, Inc.
Latest stored close $36.75 as of Oct 9, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Strong institutional accumulation. 3 accumulating across 3 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 1 sale by 1 reporting owner. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/52 non-amendment material events in the last 90 days; Latest classified evidence: Results of operations / financial condition. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +16.5% YoY; Net income +67.1% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsFiled Sep 4, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | Orszag Peter Richard | SOpen-market or private sale | Common Stock | 125.0K | $43.52 | Direct | Aug 26, 2026 |
| Aug 24, 2026 | Orszag Peter Richard | MExercise or conversion of derivative · derivative | Stock Price Profits Interest Participation Rights | 250.0K | — | Direct | Aug 26, 2026 |
| Aug 24, 2026 | Orszag Peter Richard | DDisposition to issuer | Common Stock | 75.0K | — | Direct | Aug 26, 2026 |
| Aug 24, 2026 | Orszag Peter Richard | MExercise or conversion of derivative | Common Stock | 250.0K | — | Direct | Aug 26, 2026 |
| Aug 17, 2026 | Howe Stephen R. Jr. | AGrant, award, or other acquisition · derivative | Deferred Stock Units | 103 | $0.00 | Direct | Aug 19, 2026 |
| Aug 14, 2026 | Farr Tracy | AGrant, award, or other acquisition · derivative | Restricted Stock Units | 426 | — | Direct | Aug 18, 2026 |
| Aug 14, 2026 | Soto Alexandra | AGrant, award, or other acquisition · derivative | Restricted Stock Units | 3.4K | — | Direct | Aug 18, 2026 |
| Aug 14, 2026 | Hogbin Christopher | AGrant, award, or other acquisition · derivative | Restricted Stock Units | 3.0K | — | Direct | Aug 18, 2026 |
| Aug 14, 2026 | Gathy Michael | AGrant, award, or other acquisition · derivative | Restricted Stock Units | 145 | — | Direct | Aug 18, 2026 |
| Jul 23, 2026 | Elsesser Kathy | AGrant, award, or other acquisition · derivative | Deferred Stock Units | 4.0K | $0.00 | Direct | Jul 27, 2026 |
| Jun 1, 2026 | Achleitner Ann-Kristin | AGrant, award, or other acquisition · derivative | Deferred Stock Units | 3.8K | $0.00 | Direct | Jun 3, 2026 |
| Jun 1, 2026 | Alper Andrew M | AGrant, award, or other acquisition · derivative | Deferred Stock Units | 4.1K | $0.00 | Direct | Jun 3, 2026 |
| Jun 1, 2026 | Harrison Peter | AGrant, award, or other acquisition · derivative | Deferred Stock Units | 3.8K | $0.00 | Direct | Jun 3, 2026 |
| Jun 1, 2026 | Jarrard Michelle | AGrant, award, or other acquisition · derivative | Deferred Stock Units | 4.0K | $0.00 | Direct | Jun 3, 2026 |
| Jun 1, 2026 | Knobloch Iris | AGrant, award, or other acquisition · derivative | Deferred Stock Units | 4.0K | $0.00 | Direct | Jun 3, 2026 |
| Jun 1, 2026 | SCHULMAN DANIEL H | AGrant, award, or other acquisition · derivative | Deferred Stock Units | 4.4K | $0.00 | Direct | Jun 3, 2026 |
| Jun 1, 2026 | Shevelenko Dmitry | AGrant, award, or other acquisition · derivative | Deferred Stock Units | 3.8K | $0.00 | Direct | Jun 3, 2026 |
| Jun 1, 2026 | Howe Stephen R. Jr. | AGrant, award, or other acquisition · derivative | Deferred Stock Units | 4.2K | $0.00 | Direct | Jun 3, 2026 |
| May 22, 2026 | Farr Tracy | AGrant, award, or other acquisition · derivative | Restricted Stock Units | 393 | — | Direct | May 26, 2026 |
| May 22, 2026 | Gathy Michael | AGrant, award, or other acquisition · derivative | Restricted Stock Units | 134 | — | Direct | May 26, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Jul 23, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jul 7, 2026 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jun 17, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| May 22, 2026 | 8-K | 5.03, 5.07, 9.01 | Charter or bylaw change; Shareholder vote results; Financial statements / exhibits | — | Filing |
| May 1, 2026 | 8-K | 1.01, 3.02, 7.01, 9.01 | Material definitive agreement; Unregistered sale of equity securities; Regulation FD disclosure; Financial statements / exhibits | Equity | Filing |
| May 1, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Apr 30, 2026 | 8-K | 7.01 | Regulation FD disclosure | — | Filing |
| Feb 2, 2026 | 8-K | 5.02, 7.01, 8.01, 9.01 | Director or executive change; Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| Jan 29, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Oct 23, 2025 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Mar 31, 2026 | $779.4M | +16.5% |
| Ended Sep 30, 2025 | $770.8M | -4.5% |
| Ended Jun 30, 2025 | $817.2M | +15.4% |
| Ended Mar 31, 2025 | $669.2M | -14.8% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Dec 31, 2025 | $3.2B | +1.5% |
| Ended Dec 31, 2024 | $3.1B | +21.1% |
| Ended Dec 31, 2023 | $2.6B | -9.2% |
| Ended Dec 31, 2022 | $2.9B | -12.8% |
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Aug 31, 2026 observed Sep 4, 2026 filed · 4d Schedule 13G amendment | Reported accumulation | 10.9M +3.4M | 11.20% +3.30 pts | $43.23 | $44.66 | $36.75 |
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 5.0M | $36.75 | |||
| T. Rowe Price Associates CIK0000080255 | Mar 31, 2026 observed May 15, 2026 filed · 45d Schedule 13G amendment | Reported accumulation | 9.6M +1.8M | 12.00% 0.00 pts | $42.48 | $45.23 | $36.75 |
Compare LAZ with other securities showing similar institutional activity or recent accumulation across several tracked institutions.